Caplin Point Laboratories has informed that it enclosed Compliance Certificate in terms of Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended March 31, 2022
The above information is a part of company’s filings submitted to BSE.